Northeast Financial Consultants Inc Regeneron Pharmaceuticals, Inc. Transaction History

Northeast Financial Consultants Inc

$2.25 Billion
Q3 2024

A detailed history of Northeast Financial Consultants Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 1,668 shares of REGN stock, worth $1.19 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,668

Previous 1,665 0.18%

Holding current value

$1.19 Million

Previous $1.75 Million 0.23%

% of portfolio

0.08%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$1024.09 - $1201.76 $3,072 - $3,605	3 Added 0.18%	1,668 $1.75 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $59,577 - $65,561	-66 Reduced 3.81%	1,665 $1.6 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $79,059 - $85,835	-112 Reduced 6.08%	1,731 $1.25 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $54,835 - $73,884	-100 Reduced 5.15%	1,843 $1.09 Million
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $59,512 - $69,843	100 Added 5.43%	1,943 $1.36 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $22,961 - $27,238	-40 Reduced 2.12%	1,843 $1.12 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $241,234 - $296,028	540 Added 40.21%	1,883 $891,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $19,132 - $24,319	-40 Reduced 2.89%	1,343 $649,000
Q3 2020 Oct 29, 2020	SELL	$544.75 - $658.21 $72,996 - $88,200	-134 Reduced 8.83%	1,383 $774,000
Q2 2020 Jul 30, 2020	BUY	$493.32 - $643.92 $9,866 - $12,878	20 Added 1.34%	1,517 $945,000
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $104,215 - $153,273	310 Added 26.12%	1,497 $731,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $4,111 - $5,647	-15 Reduced 1.25%	1,187 $446,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $4,101 - $4,775	-15 Reduced 1.23%	1,202 $333,000
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $14,980 - $20,741	50 Added 4.28%	1,217 $381,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $434,217 - $512,978	1,167 New	1,167 $479,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Regeneron Pharmaceuticals, Inc. Transaction History